<DOC>
	<DOCNO>NCT02961595</DOCNO>
	<brief_summary>Enterovirus infection may either increase decrease risk type 1 diabetes depend age infection type enterovirus question . This study evaluate whether early serial exposure three replication-competent enterovirus strain ( live poliovirus vaccine , OPV ) influence immunity enteroviruses possible initiation autoantibody e.g . islet autoimmunity young genetically predisposed child .</brief_summary>
	<brief_title>Live Enterovirus Vaccine Type 1 Diabetes</brief_title>
	<detailed_description>Enteroviruses associate type 1 diabetes several study . Enterovirus infection may either increase decrease risk type 1 diabetes depend age infection type enterovirus question . There remarkable homology structure poliovirus enteroviruses . It show previous study T-lymphocytes recognize structure cross-react different enterovirus serotypes . Our hypothesis poliovaccination induce cross-reacting T-cell response strengthen enterovirus immunity thus accelerate elimination enterovirus infection . We evaluate whether early serial live enterovirus vaccine ( oral polio vaccine , OPV ) influence enterovirus immunity initiation islet autoimmunity young genetically predisposed child . This study carry birth cohort ongoing Diabetes Prediction Prevention ( DIPP ) study Finland . All child carry HLA-DQ gene confer moderately increase risk type 1 diabetes ( HLA DQB1*0302/x , x≠ DQB1*0201 , *0301 , *0602 ) . Sixty-four child ( 34 male ) give dos OPV ( Polio Sabin® , SB Biologicals , Rixensart , Belgium ) age 2 , 3 , 6 12 month year 1999-2000 ( two drop per o dose ) . This vaccine include attenuated replication competent strain three poliovirus type ( polioviruses 1 , 2 , 3 ) lead infection vaccinate child . The control group comprise 251 child receive inactivated poliovirus vaccine ( IPV ) age 6 12 month accord national immunization protocol Finland time . After age 12 month group recommend continue national immunization program IPV vaccine . All child follow regularly birth blood sample take 3-12 month interval detection type 1 diabetes-associated autoantibody serum include insulin autoantibody ( IAA ) , islet cell cytoplasmic antibody ( ICA ) , insulinoma-associated protein 2 antibody ( IA-2A ) GAD antibody ( GADA ) ( 5-7 ) . Stool sample collect monthly age 2-24 month systematically screen presence enterovirus use RT-PCR .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Enterovirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>The infant parent give sign consent participate HLA genotype eligible The newborn recognizable severe illness due chromosomal abnormality , congenital malformation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Months</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Oral polio vaccine</keyword>
	<keyword>Inactivated polio vaccine</keyword>
	<keyword>Enterovirus</keyword>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Autoantibody</keyword>
</DOC>